You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Details for Patent: 5,324,824


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,324,824
Title: Metal-isonitrile adducts for preparing radionuclide complexes
Abstract:A method for preparing a coordination complex of an isonitrile ligand and a radioisotope of Tc, Ru, Co, Pt, Re, Os, Ir, W, Re, Cr, Mo, Mn, Ni, Rh, Nb and Ta from a non-radioactive metal adduct of the isonitrite.
Inventor(s): Carpenter, Jr.; Alan B. (Tyngsboro, MA), Maheu; Leo J. (Andover, MA), Patz; Michael A. (Somerville, MA), Tulip; Thomas H. (Nashua, NH), Linder; Karen E. (Somerville, MA), Subramanyam; Vinayakam (Towson, MD), Thompson; Jeffery S. (Wilmington, DE)
Assignee: The DuPont Merck Pharmaceutical Co. (Wilmington, DE)
Application Number:07/670,458
Patent Claim Types:
see list of patent claims
Device; Compound;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 5,324,824

Introduction

Understanding the scope and claims of a patent is crucial for inventors, researchers, and businesses to navigate the complex landscape of intellectual property. This article will delve into the details of United States Patent 5,324,824, exploring its claims, scope, and the broader patent landscape.

Overview of the Patent

United States Patent 5,324,824, titled "Method of Radioimaging Breast Tumors Using 'Tc-Tertiary Butyl Isonitrile Complex ('Tc-TBI) or 'Re-Tertiary Butyl Isonitrile Complex ('Re-TBI)," was granted on June 28, 1994. The inventors, Paul David Crane, David Charles Onthank, and Milind Rajopadhye, developed a novel method for diagnosing and imaging breast tumors using specific radioactive complexes.

Claims of the Patent

The claims of a patent define the scope of the invention and are critical for determining what is protected by the patent. Here are some key aspects of the claims in Patent 5,324,824:

Independent Claims

  • The patent includes several independent claims that outline the method of using 'Tc-TBI or 'Re-TBI complexes for breast tumor imaging. For example, Claim 1 describes the method of administering a composition containing 'Tc-TBI or 'Re-TBI to a mammal for diagnosing breast tumors[4].

Dependent Claims

  • Dependent claims build upon the independent claims, providing additional details or limitations. These claims may specify the composition, the method of administration, and the use of solubilization aids and reducing agents[4].

Scope of the Patent

The scope of a patent is determined by the language of the claims and is a subject of ongoing debate in patent law.

Metrics for Measuring Patent Scope

Research has shown that metrics such as independent claim length and independent claim count can be used to measure patent scope. Narrower claims, as indicated by shorter lengths and fewer counts, are often associated with a higher probability of grant and a shorter examination process[5].

Patent Scope in Context

For Patent 5,324,824, the scope is defined by the specific methods and compositions described in the claims. The invention is limited to the use of 'Tc-TBI or 'Re-TBI complexes for breast tumor imaging, which narrows the scope compared to broader claims that might encompass other imaging agents or methods.

Background of the Invention

Understanding the background of the invention provides context for the patent's claims and scope.

Prior Art

The patent references several prior art documents, including U.S. patents and foreign patent documents, that describe the use of other imaging agents like 'Tc-sestamibi for tumor imaging. The inventors built upon this prior art by developing a novel method using 'Tc-TBI or 'Re-TBI complexes, which offered improved sensitivity and specificity for breast tumor imaging[4].

Detailed Description of the Invention

The detailed description section of the patent outlines the method of diagnosing breast tumors using the specified complexes.

Administration and Composition

The method involves administering a composition containing 'Tc-TBI or 'Re-TBI parenterally to a mammal. The composition includes the imaging agent, a solubilization aid, and a reducing agent capable of reducing the radioactive metal to form the complex[4].

Patent Landscape

The patent landscape surrounding Patent 5,324,824 includes other patents and publications related to medical imaging and radioactive complexes.

Related Patents

Other patents in the field, such as those cited in the references section of Patent 5,324,824, describe similar methods and compositions for tumor imaging. These patents collectively form a body of prior art that inventors must navigate when developing new imaging agents and methods[4].

International Patent Databases

To fully understand the patent landscape, one must also consider international patent databases. Resources like the European Patent Office's esp@cenet, the Japan Patent Office, and the World Intellectual Property Organization's PATENTSCOPE provide access to global patent information, helping to identify related inventions and potential overlaps[1].

Search and Analysis Tools

Several tools and resources are available for searching and analyzing patents, which can be crucial for understanding the scope and claims of a patent like 5,324,824.

USPTO Patent Public Search

The USPTO's Patent Public Search tool allows users to search prior art and access detailed information about patents, including the claims and descriptions. This tool is essential for conducting thorough patent searches[1].

Global Dossier

The Global Dossier service provides access to the file histories of related applications from participating IP Offices, helping users to see the patent family for a specific application and understand the global context of the invention[1].

Economic and Legal Implications

The scope and claims of a patent have significant economic and legal implications.

Patent Quality and Scope

Debates over patent quality often focus on the breadth and clarity of patent claims. Patents with narrower, clearer claims are generally considered to be of higher quality and are less likely to lead to licensing and litigation issues[5].

Licensing and Litigation

The scope of a patent can affect licensing agreements and litigation outcomes. Patents with well-defined, narrow claims are easier to license and defend, reducing the risk of costly legal battles[5].

Key Takeaways

  • Claims Definition: The claims of Patent 5,324,824 define the method of using 'Tc-TBI or 'Re-TBI complexes for breast tumor imaging.
  • Scope Metrics: Metrics like independent claim length and count can help measure the scope of a patent.
  • Background and Prior Art: Understanding prior art is crucial for contextualizing the invention and its claims.
  • Patent Landscape: The patent landscape includes related patents and international databases that must be considered.
  • Search Tools: Tools like the USPTO Patent Public Search and Global Dossier are essential for analyzing patents.

FAQs

  1. What is the main invention described in Patent 5,324,824?

    • The main invention is a method of diagnosing and imaging breast tumors using 'Tc-Tertiary Butyl Isonitrile Complex ('Tc-TBI) or 'Re-Tertiary Butyl Isonitrile Complex ('Re-TBI).
  2. How are the claims of a patent defined?

    • The claims of a patent are defined by the language used in the independent and dependent claims, which outline the scope of the invention.
  3. What metrics can be used to measure patent scope?

    • Metrics such as independent claim length and independent claim count can be used to measure patent scope.
  4. Why is understanding prior art important for patent analysis?

    • Understanding prior art provides context for the invention and helps in identifying what is novel and non-obvious about the patent.
  5. What tools are available for searching and analyzing patents?

    • Tools like the USPTO Patent Public Search, Global Dossier, and international patent databases are available for searching and analyzing patents.

Sources

  1. USPTO - Search for patents https://www.uspto.gov/patents/search
  2. USA.gov - U.S. Patent and Trademark Office (USPTO) https://www.usa.gov/agencies/u-s-patent-and-trademark-office
  3. USPTO - Patent Claims Research Dataset https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. United States Patent 5,961,952 https://patentimages.storage.googleapis.com/0f/6b/35/44ccc0f66d42fd/US5961952.pdf
  5. SSRN - Patent Claims and Patent Scope https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2844964

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 5,324,824

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.